This market research report segments the global gastrointestinal (GI) stool testing market by product types (reagents and instruments), by application (colorectal cancer, diarrhea, GI tract infections, and others), by technology (PCR, end-point PCR array, integrated platform tests, and enzyme immunoassay), by test types (FOBT and clinical microbiology stool test), and by geography (APAC, EMEA, and the Americas). Leading vendors in this market are Quidel Corporation, Meridian Bioscience, Diasorin, and Clinical Genomics.
Technavio’s market research analysts estimate the global GI stool testing market to grow at a CAGR of around 7% between 2015 and 2019 due to the growing awareness of diagnostic stool test among the populace. The Americas dominate the global GI stool testing market, accounting for around 48% of the total market share. The dominance of this region can be attributed to factors like growing public awareness, increasing product launches, and FDA approvals for new instruments and fecal occult blood (FOBT) tests.
The new industry research report from Technavio provides a breakdown and analysis of the GI stool testing segments by products.
The reagents segment dominates the GI stool testing products market by occupying approximately 80% of the total market share. These are specific biological components that have the ability to identify the presence of pathogenic agents in a patient’s blood sample. Moreover, many hospitals and clinical laboratories are using stool tests for diagnosing colorectal cancer and diarrhoea.
GI stool testing segmentation by product
Source: Technavio Research
“Several physicians and clinical laboratories across the world are using point-of-care (POC) testing products, as these products are cost-effective, easily available and are convenient to use. They provide accurate results and make real-time clinical decisions quickly. POC tests such as FOBTs, are preferred by patients as they reduce in-patient hospital stays. This has encouraged vendors to focus on developing automated POC laboratory equipment and increasing their quality for home-based tests,” says Imran Mushtaq, Lead Analyst, Healthcare, Technavio Research.
Key vendors in the global GI stool testing market are Quidel Corporation, Meridian Bioscience, Diasorin, and Clinical Genomics. The market is highly fragmented and contains numerous medium and small-sized manufacturers. To maintain their market position, several companies strategically form partnerships to provide premium-priced products to end-users.
A more detailed analysis is available in the Technavio report, GI Stool Testing Market 2015-2019 – Global market research.
https://www.technavio.com/%3Cp%3E%3Cstrong%3EWe%20can%20customize%20repor…
